No Data
No Data
No Data
Analysts Offer Insights on Healthcare Companies: Takeda Pharmaceutical Co (OtherTKPHF), Opus Genetics (IRD) and CareCloud (CCLD)
Takeda Pharmaceutical Expected to Post Fourth-Quarter Net Loss -- Earnings Preview
On the 6th, the trends of ADRs showed that Hitachi, Mitsubishi UFJ, Mizuho, ETC were high in yen conversion values.
On the 6th, the ADR (American Depositary Receipt) showed mixed results compared to the Tokyo closing prices on the previous week’s Friday, with values converted to yen. In yen terms, Hitachi <6501.T>, Mitsubishi UFJ <8306.T>, Mizuho <8411.T>, JAL <9201.T>, and Nitori HD <9843.T> were on the rise. On the other hand, Takeda Pharmaceutical <4502.T>, Sony Group Corp <6758.T>, Keyence <6861.T>, Nissan Motor <7201.T>, and Honda <7267.T> were also weak. Provided by Wealth.
JT, Line Yahoo, Yokogawa Electric, Kawasaki Shipbuilding (7th)
※ The above Calendar is merely a schedule and may be subject to change at the company's convenience.--------------------------------------- May 7 (Wednesday) <165A> SBI Reos <1723> Japan Electric Technology <1870> Yahagi Construction <1967> Yamato <2003> Nitto Fuji <2053> Chubu Feeding <2281> Prima Ham <2344> Heian Ray <2902> Taiyo
Jefferies Adjusts Takeda Pharmaceutical Company's Price Target to 5,500 Yen From 5,000 Yen, Keeps at Buy
Novavax Updates Financial Terms With Takeda for Covid-19 Vaccine Agreement in Japan